Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication

Basic Research in Cardiology

Volumn 113, Issue 3, 2018, Pages

  Wider, Joseph ^a,b   Undyala, Vishnu V R ^a   Whittaker, Peter ^a   Woods, James ^a   Chen, Xuequn ^a   Przyklenk, Karin ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cardioprotection; Exosomes; Extracellular vesicles; Infarct size; Mass spectrometry; Myocardial infarction; Myocardial ischemia; Proteomics; Remote ischemic preconditioning; Type 2 diabetes

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CELL COMMUNICATION; CELL DEATH; CELL PROTECTION; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; EXOSOME; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HL-1 CELL LINE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; REMOTE ISCHEMIC PRECONDITIONING; REOXYGENATION; THERAPY EFFECT; ANIMAL; BLOOD; BLOOD FLOW; CELL LINE; DISEASE MODEL; HEART INFARCTION; HINDLIMB; ISCHEMIC PRECONDITIONING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; VASCULARIZATION; ZUCKER RAT;

ANIMALS; CELL DEATH; CELL LINE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; EXOSOMES; HINDLIMB; ISCHEMIC PRECONDITIONING; MALE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS, ZUCKER; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION;

EID: 85043787525     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-018-0674-1     Document Type: Article

References (89)

1. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, Heymes C, Martinez MC, Andriantsitohaina R (2008) Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 173:1210–1219. https://doi.org/10.2353/ajpath.2008.080228
2. Ailawadi S, Wang X, Gu H, Fan GC (2015) Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim Biophys Acta 1852:1–11. https://doi.org/10.1016/j.bbadis.2014.10.008
3. Alegria JR, Miller TD, Gibbons RJ, Yi QL, Yusuf S, Collaborative Organization of RheothRx Evaluation Trial I (2007) Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. Am Heart J 154:743–750. https://doi.org/10.1016/j.ahj.2007.06.020
4. Baranyai T, Herczeg K, Onodi Z, Voszka I, Modos K, Marton N, Nagy G, Mager I, Wood MJ, El Andaloussi S, Palinkas Z, Kumar V, Nagy P, Kittel A, Buzas EI, Ferdinandy P, Giricz Z (2015) Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS ONE 10:e0145686. https://doi.org/10.1371/journal.pone.0145686
5. Baranyai T, Nagy CT, Koncsos G, Onodi Z, Karolyi-Szabo M, Makkos A, Varga ZV, Ferdinandy P, Giricz Z (2015) Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning. Cardiovasc Diabetol 14:151. https://doi.org/10.1186/s12933-015-0313-1
6. Barile L, Moccetti T, Marban E, Vassalli G (2017) Roles of exosomes in cardioprotection. Eur Heart J 38:1372–1379. https://doi.org/10.1093/eurheartj/ehw304
7. Bauer B, Simkhovich BZ, Kloner RA, Przyklenk K (1999) Preconditioning-induced cardioprotection and release of the second messenger inositol (1,4,5)-trisphosphate are both abolished by neomycin in rabbit heart. Basic Res Cardiol 94:31–40
8. Behmenburg F, Heinen A, Bruch LV, Hollmann MW, Huhn R (2017) Cardioprotection by remote ischemic preconditioning is blocked in the aged rat heart in vivo. J Cardiothorac Vasc Anesth 31:1223–1226. https://doi.org/10.1053/j.jvca.2016.07.005
9. Bouhidel O, Pons S, Souktani R, Zini R, Berdeaux A, Ghaleh B (2008) Myocardial ischemic postconditioning against ischemia–reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol 295:H1580–H1586. https://doi.org/10.1152/ajpheart.00379.2008
10. Brussee V, Guo G, Dong Y, Cheng C, Martinez JA, Smith D, Glazner GW, Fernyhough P, Zochodne DW (2008) Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model. Diabetes 57:1664–1673. https://doi.org/10.2337/db07-1737
11. Castellano J, Farre J, Fernandes J, Bayes-Genis A, Cinca J, Badimon L, Hove-Madsen L, Llorente-Cortes V (2011) Hypoxia exacerbates Ca(2+)-handling disturbances induced by very low density lipoproteins (VLDL) in neonatal rat cardiomyocytes. J Mol Cell Cardiol 50:894–902. https://doi.org/10.1016/j.yjmcc.2011.02.002
12. Chandramouli K, Qian PY (2009) Proteomics: challenges, techniques and possibilities to overcome biological sample complexity. Hum Genom Proteom. https://doi.org/10.4061/2009/239204
13. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ Jr (1998) HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95:2979–2984
14. Davidson SM, Riquelme JA, Takov K, Vicencio JM, Boi-Doku C, Khoo V, Doreth C, Radenkovic D, Lavandero S, Yellon DM (2018) Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro. J Cell Mol Med 22:141–151. https://doi.org/10.1111/jcmm.13302
15. Davidson SM, Takov K, Yellon DM (2017) Exosomes and cardiovascular protection. Cardiovasc Drugs Ther 31:77–86. https://doi.org/10.1007/s10557-016-6698-6
16. de Couto G, Liu W, Tseliou E, Sun B, Makkar N, Kanazawa H, Arditi M, Marban E (2015) Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest 125:3147–3162. https://doi.org/10.1172/jci81321
17. de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M (2003) Lipid raft-associated protein sorting in exosomes. Blood 102:4336–4344. https://doi.org/10.1182/blood-2003-03-0871
18. Dong Y, Undyala VVR, Przyklenk K (2016) Inhibition of mitochondrial fission as a molecular target for cardioprotection: critical importance of the timing of treatment. Basic Res Cardiol 111:59. https://doi.org/10.1007/s00395-016-0578-x
19. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, Harrison P, Sargent IL (2011) Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine 7:780–788. https://doi.org/10.1016/j.nano.2011.04.003
20. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R (2014) Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 66:1142–1174. https://doi.org/10.1124/pr.113.008300
21. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W (1981) Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 101:593–600
22. Gallet R, Dawkins J, Valle J, Simsolo E, de Couto G, Middleton R, Tseliou E, Luthringer D, Kreke M, Smith RR, Marban L, Ghaleh B, Marban E (2016) Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J. https://doi.org/10.1093/eurheartj/ehw240
23. Garratt KN, Whittaker P, Przyklenk K (2016) Remote ischemic conditioning and the long road to clinical translation: lessons learned from ERICCA and RIPHeart. Circ Res 118:1052–1054. https://doi.org/10.1161/circresaha.115.308102
24. Giblett JP, Hoole SP (2017) Remote ischemic conditioning in elective PCI? J Cardiovasc Pharmacol Ther 22:310–315. https://doi.org/10.1177/1074248417702479
25. Giricz Z, Varga ZV, Baranyai T, Sipos P, Paloczi K, Kittel A, Buzas EI, Ferdinandy P (2014) Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol 68:75–78. https://doi.org/10.1016/j.yjmcc.2014.01.004
26. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB (2014) Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 129:e28–e292. https://doi.org/10.1161/01.cir.0000441139.02102.80
27. Gu W, Kehl F, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR (2008) Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism. Anesthesiology 108:634–642. https://doi.org/10.1097/aln.0b013e3181672590
28. Guitart K, Loers G, Buck F, Bork U, Schachner M, Kleene R (2016) Improvement of neuronal cell survival by astrocyte-derived exosomes under hypoxic and ischemic conditions depends on prion protein. Glia 64:896–910. https://doi.org/10.1002/glia.22963
29. Gupta S, Knowlton AA (2007) HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 292:H3052–H3056. https://doi.org/10.1152/ajpheart.01355.2006
30. Hausenloy DJ, Wynne AM, Mocanu MM, Yellon DM (2013) Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart. J Cardiovasc Pharmacol Ther 18:263–269. https://doi.org/10.1177/1074248412468945
31. Helgeland E, Breivik LE, Vaudel M, Svendsen OS, Garberg H, Nordrehaug JE, Berven FS, Jonassen AK (2014) Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning—a word of caution. PLoS ONE 9:e109279. https://doi.org/10.1371/journal.pone.0109279
32. Hepponstall M, Ignjatovic V, Binos S, Attard C, Karlaftis V, d’Udekem Y, Monagle P, Konstantinov IE (2015) Remote ischemic preconditioning (RIPC) modifies the plasma proteome in children undergoing repair of tetralogy of fallot: a randomized controlled trial. PLoS ONE 10:e0122778. https://doi.org/10.1371/journal.pone.0122778
33. Hepponstall M, Ignjatovic V, Binos S, Monagle P, Jones B, Cheung MH, d’Udekem Y, Konstantinov IE (2012) Remote ischemic preconditioning (RIPC) modifies plasma proteome in humans. PLoS ONE 7:e48284. https://doi.org/10.1371/journal.pone.0048284
34. Heusch G (2017) Critical issues for the translation of cardioprotection. Circ Res 120:1477–1486. https://doi.org/10.1161/circresaha.117.310820
35. Heusch G (2017) Remote ischemic conditioning in cardiovascular surgery. J Cardiovasc Pharmacol Ther 22:297–301. https://doi.org/10.1177/1074248416687874
36. Heusch G, Botker HE, Przyklenk K, Redington A, Yellon D (2015) Remote ischemic conditioning. J Am Coll Cardiol 65:177–195. https://doi.org/10.1016/j.jacc.2014.10.031
37. Hibert P, Prunier-Mirebeau D, Beseme O, Chwastyniak M, Tamareille S, Lamon D, Furber A, Pinet F, Prunier F (2013) Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning. PLoS ONE 8:e77211. https://doi.org/10.1371/journal.pone.0077211
38. Hibert P, Prunier-Mirebeau D, Beseme O, Chwastyniak M, Tamareille S, Pinet F, Prunier F (2014) Modifications in rat plasma proteome after remote ischemic preconditioning (RIPC) stimulus: identification by a SELDI–TOF–MS approach. PLoS ONE 9:e85669. https://doi.org/10.1371/journal.pone.0085669
39. Himori N, Matsuura A (1989) A simple technique for occlusion and reperfusion of coronary artery in conscious rats. Am J Physiol 256:H1719–H1725
40. Horsburgh K, Kelly S, McCulloch J, Higgins GA, Roses AD, Nicoll JA (1999) Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia. NeuroReport 10:837–841
41. Ibrahim AG, Cheng K, Marban E (2014) Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep 2:606–619. https://doi.org/10.1016/j.stemcr.2014.04.006
42. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, Umemura T, Nakamura S, Yoshida M (2003) Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 92:288–291
43. Jensen RV, Stottrup NB, Kristiansen SB, Botker HE (2012) Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Basic Res Cardiol 107:285. https://doi.org/10.1007/s00395-012-0285-1
44. Jones WK, Fan GC, Liao S, Zhang JM, Wang Y, Weintraub NL, Kranias EG, Schultz JE, Lorenz J, Ren X (2009) Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling. Circulation 120:S1–S9. https://doi.org/10.1161/circulationaha.108.843938
45. Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW (2007) Myocardial preconditioning against ischemia–reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 292:R920–R926. https://doi.org/10.1152/ajpregu.00520.2006
46. Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Warltier DC (1998) Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol 275:H721–H725
47. Kleinbongard P, Skyschally A, Heusch G (2017) Cardioprotection by remote ischemic conditioning and its signal transduction. Pflugers Arch 469:159–181. https://doi.org/10.1007/s00424-016-1922-6
48. Kottenberg E, Thielmann M, Kleinbongard P, Frey UH, Heine T, Jakob H, Heusch G, Peters J (2014) Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation. Acta Anaesthesiol Scand 58:453–462. https://doi.org/10.1111/aas.12278
49. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyvbjerg A (2004) Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 47:1716–1721. https://doi.org/10.1007/s00125-004-1514-4
50. Lang SC, Elsasser A, Scheler C, Vetter S, Tiefenbacher CP, Kubler W, Katus HA, Vogt AM (2006) Myocardial preconditioning and remote renal preconditioning—identifying a protective factor using proteomic methods? Basic Res Cardiol 101:149–158. https://doi.org/10.1007/s00395-005-0565-0
51. Lee JS, Wu Y, Schnepp P, Fang J, Zhang X, Karnovsky A, Woods J, Stemmer PM, Liu M, Zhang K, Chen X (2015) Proteomics analysis of rough endoplasmic reticulum in pancreatic beta cells. Proteomics 15:1508–1511. https://doi.org/10.1002/pmic.201400345
52. Li J, Rohailla S, Gelber N, Rutka J, Sabah N, Gladstone RA, Wei C, Hu P, Kharbanda RK, Redington AN (2014) MicroRNA-144 is a circulating effector of remote ischemic preconditioning. Basic Res Cardiol 109:423. https://doi.org/10.1007/s00395-014-0423-z
53. Li YW, Whittaker P, Kloner RA (1992) The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J 123:346–353
54. Lindsey ML, Bolli R, Canty JM, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner R, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G (2018) Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol. https://doi.org/10.1152/ajpheart.00335.2017
55. Ma F, Liu H, Shen Y, Zhang Y, Pan S (2015) Platelet-derived microvesicles are involved in cardio-protective effects of remote preconditioning. Int J Clin Exp Pathol 8:10832–10839
56. Ma LL, Kong FJ, Guo JJ, Zhu JB, Shi HT, Li Y, Sun RH, Ge JB (2017) Hypercholesterolemia abrogates remote ischemic preconditioning-induced cardioprotection: role of reperfusion injury salvage kinase signals. Shock 47:363–369. https://doi.org/10.1097/shk.0000000000000737
57. Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Mehran R, Krucoff MW, Lansky AJ, Stone GW (2007) Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Am J Cardiol 100:206–210. https://doi.org/10.1016/j.amjcard.2007.02.080
58. Martinez MC, Andriantsitohaina R (2017) Extracellular vesicles in metabolic syndrome. Circ Res 120:1674–1686. https://doi.org/10.1161/circresaha.117.309419
59. Miki T, Itoh T, Sunaga D, Miura T (2012) Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol 11:67. https://doi.org/10.1186/1475-2840-11-67
60. Momen-Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, Skog J, Kuo WP (2012) Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front Physiol 3:162. https://doi.org/10.3389/fphys.2012.00162
61. Oberkofler CE, Limani P, Jang JH, Rickenbacher A, Lehmann K, Raptis DA, Ungethuem U, Tian Y, Grabliauskaite K, Humar R, Graf R, Humar B, Clavien PA (2014) Systemic protection through remote ischemic preconditioning is spread by platelet-dependent signaling in mice. Hepatology 60:1409–1417. https://doi.org/10.1002/hep.27089
62. Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA (2005) Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J Physiol Endocrinol Metab 289:E113–E122. https://doi.org/10.1152/ajpendo.00594.2004
63. Oosterlinck W, Dresselaers T, Geldhof V, Nevelsteen I, Janssens S, Himmelreich U, Herijgers P (2013) Diabetes mellitus and the metabolic syndrome do not abolish, but might reduce, the cardioprotective effect of ischemic postconditioning. J Thorac Cardiovasc Surg 145:1595–1602. https://doi.org/10.1016/j.jtcvs.2013.02.016
64. Pang T, Zhao Y, Zhang NR, Jin SQ, Pan SQ (2013) Transient limb ischemia alters serum protein expression in healthy volunteers: complement C3 and vitronectin may be involved in organ protection induced by remote ischemic preconditioning. Oxid Med Cell Longev 2013:859056. https://doi.org/10.1155/2013/859056
65. Perman JC, Bostrom P, Lindbom M, Lidberg U, StAhlman M, Hagg D, Lindskog H, Scharin Tang M, Omerovic E, Mattsson Hulten L, Jeppsson A, Petursson P, Herlitz J, Olivecrona G, Strickland DK, Ekroos K, Olofsson SO, Boren J (2011) The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. J Clin Investig 121:2625–2640. https://doi.org/10.1172/jci43068
66. Pickard JM, Botker HE, Crimi G, Davidson B, Davidson SM, Dutka D, Ferdinandy P, Ganske R, Garcia-Dorado D, Giricz Z, Gourine AV, Heusch G, Kharbanda R, Kleinbongard P, MacAllister R, McIntyre C, Meybohm P, Prunier F, Redington A, Robertson NJ, Suleiman MS, Vanezis A, Walsh S, Yellon DM, Hausenloy DJ (2015) Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop. Basic Res Cardiol 110:453. https://doi.org/10.1007/s00395-014-0453-6
67. Przyklenk K (2015) Ischaemic conditioning: pitfalls on the path to clinical translation. Br J Pharmacol 172:1961–1973. https://doi.org/10.1111/bph.13064
68. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P (1993) Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87:893–899
69. Przyklenk K, Maynard M, Greiner DL, Whittaker P (2011) Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal 14:781–790. https://doi.org/10.1089/ars.2010.3343
70. Rana S, Yue S, Stadel D, Zoller M (2012) Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol 44:1574–1584. https://doi.org/10.1016/j.biocel.2012.06.018
71. Riess ML, Rhodes SS, Stowe DF, Aldakkak M, Camara AK (2009) Comparison of cumulative planimetry versus manual dissection to assess experimental infarct size in isolated hearts. J Pharmacol Toxicol Methods 60:275–280. https://doi.org/10.1016/j.vascn.2009.05.012
72. Schmidt MR, Rasmussen ME, Botker HE (2017) Remote ischemic conditioning for patients with STEMI. J Cardiovasc Pharmacol Ther 22:302–309. https://doi.org/10.1177/1074248417702481
73. Selvin E, Parrinello CM, Sacks DB, Coresh J (2014) Trends in prevalence and control of diabetes in the United States, 1988–1994 and 1999–2010. Ann Intern Med 160:517–525. https://doi.org/10.7326/m13-2411
74. Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, Li J, Gross G, Wilson GJ, Callahan J, Redington AN (2009) Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 117:191–200. https://doi.org/10.1042/cs20080523
75. Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P, Heusch G (2015) Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways. Circ Res 117:279–288. https://doi.org/10.1161/circresaha.117.306878
76. Thery C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 3:22. https://doi.org/10.1002/0471143030.cb0322s30
77. Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J (1993) Protection from ischaemic–reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels. Cardiovasc Res 27:623–629
78. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM (2005) Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 54:2360–2364
79. Vicencio JM, Yellon DM, Sivaraman V, Das D, Boi-Doku C, Arjun S, Zheng Y, Riquelme JA, Kearney J, Sharma V, Multhoff G, Hall AR, Davidson SM (2015) Plasma exosomes protect the myocardium from ischemia–reperfusion injury. J Am Coll Cardiol 65:1525–1536. https://doi.org/10.1016/j.jacc.2015.02.026
80. Wagner C, Kloeting I, Strasser RH, Weinbrenner C (2008) Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol 52:430–437. https://doi.org/10.1097/fjc.0b013e31818c12a7
81. Wang H, Anderson LG, Lascola CD, James ML, Venkatraman TN, Bennett ER, Acheson SK, Vitek MP, Laskowitz DT (2013) ApolipoproteinE mimetic peptides improve outcome after focal ischemia. Exp Neurol 241:67–74. https://doi.org/10.1016/j.expneurol.2012.11.027
82. White SM, Constantin PE, Claycomb WC (2004) Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 286:H823–H829. https://doi.org/10.1152/ajpheart.00986.2003
83. Whittaker P, Kloner RA, Przyklenk K (1996) Intramyocardial injections and protection against myocardial ischemia. An attempt to examine the cardioprotective actions of adenosine. Circulation 93:2043–2057
84. Whittaker P, Przyklenk K (1994) Reduction of infarct size in vivo with ischemic preconditioning: mathematical evidence for protection via non-ischemic tissue. Basic Res Cardiol 89:6–15
85. Whittington HJ, Harding I, Stephenson CI, Bell R, Hausenloy DJ, Mocanu MM, Yellon DM (2013) Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling. Cardiovasc Res 99:694–704. https://doi.org/10.1093/cvr/cvt140
86. Wider J, Przyklenk K (2014) Ischemic conditioning: the challenge of protecting the diabetic heart. Cardiovasc Diagn Ther 4:383–396. https://doi.org/10.3978/j.issn.2223-3652.2014.10.05
87. Yang Z, Tian Y, Liu Y, Hennessy S, Kron IL, French BA (2013) Acute hyperglycemia abolishes ischemic preconditioning by inhibiting Akt phosphorylation: normalizing blood glucose before ischemia restores ischemic preconditioning. Oxid Med Cell Longev 2013:329183. https://doi.org/10.1155/2013/329183
88. Zalesak M, Blazicek P, Pancza D, Ledvenyiova V, Bartekova M, Nemcekova M, Carnicka S, Ziegelhoffer A, Ravingerova T (2014) Severity of lethal ischemia/reperfusion injury in rat hearts subjected to ischemic preconditioning is increased under conditions of simulated hyperglycemia. Physiol Res 63:577–585
89. Zhu SG, Xi L, Kukreja RC (2012) Type 2 diabetic obese db/db mice are refractory to myocardial ischaemic post-conditioning in vivo: potential role for Hsp 20, F1-ATPase delta and Echs1. J Cell Mol Med 16:950–958. https://doi.org/10.1111/j.1582-4934.2011.01376.x